ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

CollPlant Biotechnologies Ltd (CLGN)

NASDAQ

$0.80

$+0.03

(+3.33%)

CollPlant Biotechnologies Ltd (CLGN) Live Price Chart

Page last updated: 2026-02-06 21:12:00

Key Market Data

Market Cap	$10.23M
Open	$0.83
High	$24.26
Low	$0.66
Previous Close	$0.75
Price Change	$+0.03
Percentage Change	+3.33%
Volume	285K

CollPlant Biotechnologies Ltd (CLGN) Stock Price Today

CollPlant Biotechnologies Ltd (CLGN) is currently trading at $0.80 as of 2026-02-06 21:12:00, reflecting a +3.33% move ($+0.03) from the previous close.

In the short term, the stock has returned -4,437.50% over the past four weeks. Over the last 12 months, CollPlant Biotechnologies Ltd has recorded a -78.45% price change, indicating a weak performance relative to the broader market.

CollPlant Biotechnologies Ltd (CLGN) 7-Day Stock Price Changes

Over the past seven days, CollPlant Biotechnologies Ltd has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $1.83 to the latest recorded price of $0.80, reflecting an intraday change of +3.33%. Daily movements highlight shifts in trading volume (284,831), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, CLGN has delivered a -4,437.50% return over the past month and a -78.45% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy CollPlant Biotechnologies Ltd (CLGN)

You can buy and trade CLGN on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for CLGN and Execute Your Trade

Open the trading page, enter CLGN in the search bar, select the amount of CLGN you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is CollPlant Biotechnologies Ltd (CLGN)?

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

CollPlant Biotechnologies Ltd Information

Industry	--
Employees	57
Sector	--
Company Website	https://www.collplant.com

Frequently Asked Questions (FAQ)

1.What is the current share price of CollPlant Biotechnologies Ltd?

The latest trading price for CollPlant Biotechnologies Ltd (Common Stock) is $ 0.80, compared with a previous closing price of $ 0.75. That means the stock has moved +3.33% so far today. Intraday price updates and recent trading activity for CLGN can be tracked on the live chart and quote section on this page.

2.Is CollPlant Biotechnologies Ltd stock going up or down?

Looking at recent performances, CLGN has returned -4,437.50% over the past month, -73.12% over the last six months and -78.45% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for CollPlant Biotechnologies Ltd stock, but keep in mind that past returns do not guarantee future results.

3.Where does CLGN currently sit relative to its 52-week high and low?

In the most recent 52-week period, CollPlant Biotechnologies Ltd has traded between a low of $ 0.66 and a high of $ 4.98. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether CLGN is currently nearer the top or the bottom of its one-year trading band.

4.How is CollPlant Biotechnologies Ltd classified by sector and industry?

CollPlant Biotechnologies Ltd is classified in the -- sector, within the -- industry group and the -- industry. In practice, this means CollPlant Biotechnologies Ltd is grouped with companies that face similar end-markets, competitive dynamics and regulatory environments. For investors, knowing CLGN's sector and industry classification helps when building diversified portfolios, comparing CollPlant Biotechnologies Ltd with direct peers, and understanding how stock-specific risks such as -- may be influenced by broader trends in the -- sector and -- industry.

5.Where is CollPlant Biotechnologies Ltd listed and how large is it by market value?

CollPlant Biotechnologies Ltd is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 10.23M, the company is classified as a Small-cap stock. Market cap gives a quick sense of CollPlant Biotechnologies Ltd's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does CLGN's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit CollPlant Biotechnologies Ltd has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track CollPlant Biotechnologies Ltd's financial performance over time?

To follow CollPlant Biotechnologies Ltd's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how CLGN is performing and how the market is responding.

8.When is CollPlant Biotechnologies Ltd expected to report earnings?

CollPlant Biotechnologies Ltd's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for CLGN, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in CollPlant Biotechnologies Ltd's earnings reports?

CollPlant Biotechnologies Ltd's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether CLGN is meeting, beating or missing expectations.

10.How can I stay informed about CollPlant Biotechnologies Ltd's results and guidance?

You can stay up to date on CollPlant Biotechnologies Ltd by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for CLGN on this page helps you see how new information is being reflected in the stock.

11.Does CollPlant Biotechnologies Ltd pay a regular cash dividend to its shareholders?

CollPlant Biotechnologies Ltd Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor CLGN's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for CLGN?

Based on the latest earnings data, CLGN has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether CollPlant Biotechnologies Ltd is an attractive income stock. The dividend payout ratio measures what percentage of earnings CollPlant Biotechnologies Ltd distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is CollPlant Biotechnologies Ltd?

CollPlant Biotechnologies Ltd is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is CLGN valued in terms of P/E ratio and EPS?

CollPlant Biotechnologies Ltd currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of CollPlant Biotechnologies Ltd's earnings. Comparing CLGN's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as CollPlant Biotechnologies Ltd

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

ALX Oncology Holdings Inc.

Definium Therapeutics, Inc.

DFTX

Top Gainers

Browse today's leading gainers in the US stock market

TuHURA Biosciences, Inc.

HURA

Jiuzi Holdings, Inc.

JZXN

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

CLGN-to-USD Calculator

Amount

CLGN

USD

1 CLGN = 0.801 USD